Pediatric practices nationwide are rolling out standardized anxiety screening as part of well-child visits for ages 12-18.
The shift follows updated task-force guidance and insurer reimbursement changes that now cover brief validated instruments.
Clinicians say referral pathways remain the harder problem, with wait lists for adolescent therapy stretching months in many regions.
